ArticleThe Journal of investigative dermatology2015
Obesity and risks for malignant melanoma and non-melanoma skin cancer: results from a large Danish prospective cohort study.
Article in The Journal of investigative dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Body mass index and risk of non-melanoma skin cancer: cumulative evidence from prospective studies.Scientific reports · 2016Pooled it
- Association between Obesity and Melanoma Risk in an Asian Population: A Nationwide Cohort Study.Cancer research and treatment · 2026Article
- Analysis of Body Composition and Levels of Antimicrobial Peptides in Patients with Basal Cell Carcinoma: A Preliminary Study.Journal of clinical medicine · 2025Article
- A genetically informed study reveals modifiable pathways in skin cancer.Journal of translational medicine · 2024Article
- Article
- Unraveling the Obesity Paradox: Exploring the Impact of Body Weight on Cutaneous Melanoma Prognosis in Asian Population.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024Article
- Evaluating the effect of body mass index and 25-hydroxy-vitamin D level on basal cell carcinoma using Mendelian randomization.Scientific reports · 2023Article
- Modeling the effects of genetic- and diet-induced obesity on melanoma progression in zebrafish.Disease models & mechanisms · 2023Article
- The Impact of Obesity on Surgically Treated Locoregional Melanoma.Annals of surgical oncology · 2021Article
- Body Mass Index and Melanoma Prognosis.Dermatology practical & conceptual · 2021Review
- Daily Lifestyle and Cutaneous Malignancies.International journal of molecular sciences · 2021Review
- Melanoma Progression under Obesity: Focus on Adipokines.Cancers · 2021Review
- Adipokines in the Skin and in Dermatological Diseases.International journal of molecular sciences · 2020Review
- Do Diet and Lifestyles Play a Role in the Pathogenesis of NMSCs?Nutrients · 2020Article
- Epidemiology of nonmelanoma skin cancer in Japan: Occupational type, lifestyle, and family history of cancer.Cancer science · 2020Article
- The role of leptin in selected skin diseases.Lipids in health and disease · 2020Review
- The Important Role of Leptin in Modulating the Risk of Dermatological Diseases.Frontiers in immunology · 2020Review
- Waist circumference and risk of 23 site-specific cancers: a population-based cohort study of Korean adults.British journal of cancer · 2018Article
- Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins.Cancer discovery · 2018Article
- Epidemiology of Keratinocyte Carcinoma.Current dermatology reports · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
25290686What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.